UK markets close in 2 hours 12 minutes

Titan Medical Inc. (TMDIF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.03530.0000 (0.00%)
At close: 03:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.58M
Enterprise value 88.40k
Trailing P/E 0.50
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.23
Price/book (mrq)1.06
Enterprise value/revenue 0.01
Enterprise value/EBITDA 0.01

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-73.33%
S&P500 52-week change 323.49%
52-week high 30.1800
52-week low 30.0300
50-day moving average 30.0438
200-day moving average 30.0746

Share statistics

Avg vol (3-month) 3107.36k
Avg vol (10-day) 352.35k
Shares outstanding 5114.04M
Implied shares outstanding 6129.84M
Float 880.36M
% held by insiders 10.42%
% held by institutions 10.37%
Shares short (28 Feb 2023) 41.49M
Short ratio (28 Feb 2023) 40.16
Short % of float (28 Feb 2023) 41.33%
Short % of shares outstanding (28 Feb 2023) 41.33%
Shares short (prior month 31 Jan 2023) 4132.2k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 319 Jun 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 49.44%
Operating margin (ttm)69.53%

Management effectiveness

Return on assets (ttm)136.53%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)17.63M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 12.46M
Net income avi to common (ttm)8.72M
Diluted EPS (ttm)0.0700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.71M
Total cash per share (mrq)0.07
Total debt (mrq)1.21M
Total debt/equity (mrq)32.00%
Current ratio (mrq)3.12
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)4.88M
Levered free cash flow (ttm)2.08M